Market Overview

UPDATE: Bank of America Merrill Lynch Reiterates Buy Rating, Raises PT on Stryker Corporation

Related SYK
Brean Digs Into Osiris Therapeutics 10Q, Downgrades To Sell
Earnings Scheduled For October 22, 2015

In a report published Wednesday, Bank of America Merrill Lynch reiterated its Buy rating on Stryker Corporation (NYSE: SYK), and raised its price target from $57.00 to $67.00.

BofA Merrill Lynch noted, “Over the last 10 years, SYK has traded at a 33% P/E premium to the S&P, but since 2008, the average premium has been reduced to below 20%. Our PO assumes SYK's premium increases back up to the 20% area as investors get more comfortable with SYK's ability to maintain and grow margins despite a tough environment and as investors gain confidence that the weak economy is not on the verge of driving another downtick in top-line growth.”

Stryker Corporation closed on Tuesday at $55.81.

Latest Ratings for SYK

Nov 2015Goldman SachsDowngradesBuyNeutral
Nov 2015CitigroupInitiates Coverage onSell
Nov 2015Sterne Agee CRTInitiates Coverage onNeutral

View More Analyst Ratings for SYK
View the Latest Analyst Ratings

Posted-In: Bank of America Merrill LynchAnalyst Color Price Target Analyst Ratings


Related Articles (SYK)

View Comments and Join the Discussion!

Get Benzinga's Newsletters